Ectopic expression of RBP4 impairs the insulin pathway and inguinal fat deposition in mice
Jia Cheng1, Yuefeng Li, Guofang Wu
1College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, 712100, China.
Abstract:
A large body of evidence has linked retinol-binding protein 4 (RBP4) to systemic insulin resistance, but little is known about its function in fat deposition. This study aimed to confirm the involvement of RBP4 in inguinal fat deposition and insulin by intraperitoneal injection of adenovirus-mediated RBP4 to mice. Intraperitoneal injection of adenoviral vectors was validated as an efficient gene manipulation tool for over-expressing recombinant proteins in vivo. Ectopic expression of RBP4 decelerated inguinal fat deposition by decreasing the size of adipocytes. Moreover, the introduction of exogenous RBP4 blunted the response of inguinal adipocytes to insulin signals. These findings suggest that RBP4 impaired in vivo adipogenesis, partly through the repression of the insulin pathway.
Insights
Retinol-binding protein 4 (RBP4) was found to hinder fat cell growth and impair insulin signaling in mice. This suggests RBP4 plays a role in reducing fat deposition and improving insulin sensitivity.
Area of Science:
- Metabolism and Endocrinology
- Adipocyte Biology
- Molecular Biology
Background:
- Retinol-binding protein 4 (RBP4) is linked to systemic insulin resistance.
- The precise role of RBP4 in fat deposition remains largely uncharacterized.
Purpose of the Study:
- To investigate the function of RBP4 in regulating inguinal fat deposition.
- To determine the effect of RBP4 on adipocyte insulin signaling in vivo.
Main Methods:
- Adenovirus-mediated RBP4 overexpression in mice via intraperitoneal injection.
- Assessment of adipocyte size and insulin response in inguinal fat tissue.
- Validation of adenoviral vectors for in vivo gene manipulation.
Main Results:
- Ectopic RBP4 expression reduced inguinal fat deposition by decreasing adipocyte size.
- Exogenous RBP4 introduction attenuated the response of inguinal adipocytes to insulin.
- Adenoviral vectors proved effective for in vivo recombinant protein overexpression.
Conclusions:
- RBP4 impairs in vivo adipogenesis, partly by repressing the insulin signaling pathway.
- RBP4 may represent a therapeutic target for metabolic disorders involving insulin resistance and altered fat deposition.
More Related Videos
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...


